GRAIL, Inc. (GRAL)
67.86
+1.83
(+2.77%)
USD |
NASDAQ |
May 21, 16:00
67.85
-0.01
(-0.01%)
After-Hours: 19:59
GRAIL Research and Development Expense (TTM) : 185.25M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Veracyte, Inc. | 79.31M |
| Insight Molecular Diagnostics, Inc. | 16.63M |
| Exagen, Inc. | 6.523M |
| bioAffinity Technologies, Inc. | 2.267M |
| Biodesix, Inc. | 12.42M |